Apogee Other Stockholder Equity from 2010 to 2025
| APGE Stock | 39.72 0.47 1.20% |
Other Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 1 B | Current Value 653.5 M | Quarterly Volatility 212.7 M |
Check Apogee Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apogee Therapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 36.5 M, Interest Income of 36.5 M or Depreciation And Amortization of 7.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.66. Apogee financial statements analysis is a perfect complement when working with Apogee Therapeutics, Valuation or Volatility modules.
Apogee |
Latest Apogee Therapeutics,'s Other Stockholder Equity Growth Pattern
Below is the plot of the Other Stockholder Equity of Apogee Therapeutics, Common over the last few years. It is Apogee Therapeutics,'s Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apogee Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| Other Stockholder Equity | 10 Years Trend |
|
Other Stockholder Equity |
| Timeline |
Apogee Other Stockholder Equity Regression Statistics
| Arithmetic Mean | 345,006,052 | |
| Geometric Mean | 309,759,959 | |
| Coefficient Of Variation | 61.66 | |
| Mean Deviation | 142,949,710 | |
| Median | 257,037,000 | |
| Standard Deviation | 212,738,630 | |
| Sample Variance | 45257.7T | |
| Range | 764.8M | |
| R-Value | 0.61 | |
| Mean Square Error | 30324.6T | |
| R-Squared | 0.37 | |
| Significance | 0.01 | |
| Slope | 27,349,692 | |
| Total Sum of Squares | 678865.9T |
Apogee Other Stockholder Equity History
About Apogee Therapeutics, Financial Statements
Apogee Therapeutics, stakeholders use historical fundamental indicators, such as Apogee Therapeutics,'s Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Apogee Therapeutics, investors may analyze each financial statement separately, they are all interrelated. For example, changes in Apogee Therapeutics,'s assets and liabilities are reflected in the revenues and expenses on Apogee Therapeutics,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Apogee Therapeutics, Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Stockholder Equity | 1 B | 653.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Apogee Therapeutics, Correlation against competitors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apogee Therapeutics,. If investors know Apogee will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apogee Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Apogee Therapeutics, is measured differently than its book value, which is the value of Apogee that is recorded on the company's balance sheet. Investors also form their own opinion of Apogee Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Apogee Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apogee Therapeutics,'s market value can be influenced by many factors that don't directly affect Apogee Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apogee Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Apogee Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apogee Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.